See the DrugPatentWatch profile for vascepa

Based on the information provided, there is no direct mention of users noting an energy boost with Vascepa use. Vascepa (icosapent ethyl) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to lower the risk of heart attack and stroke in adults with known cardiovascular disease or diabetes and two or more additional risk factors for cardiovascular disease [1].

Vascepa contains a highly purified form of eicosapentaenoic acid (EPA), a type of omega-3 fatty acid [1]. It works by reducing the production of triglycerides, a type of fat, in the body [1]. The medication's primary benefits are associated with heart health and do not include energy enhancement as a known effect [1].

It is important to consult with a healthcare professional or pharmacist for personalized information regarding Vascepa and its potential effects [1]. They can provide guidance based on a comprehensive understanding of a patient's medical history and current health status.

Sources:

[1] DrugPatentWatch.com. (n.d.). Vascepa - Icosapent Ethyl. Retrieved from https://www.drugpatentwatch.com/drugs/vascepa